Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Rizzetto

Showing results (21-30 of 198) with videos related to

Pageof 20
Sort By:
Journal of Medical Virology|July 13, 2002
Progress in the prevention and control of viral hepatitis type B: closing remarksMario Rizzetto, Alessandro R Zanetti
Journal of Hepatology|January 23, 2021
The changing context of hepatitis DMario Rizzetto, Saeed Hamid, Franco Negro
Biomedicines|March 25, 2022
Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?Giorgio Maria Saracco, Alfredo Marzano, Mario Rizzetto
Viruses|August 26, 2022
A Review of HDV InfectionGian Paolo Caviglia, Alessia Ciancio, Mario Rizzetto
The Lancet. Infectious Diseases|March 21, 2008
Helicobacter species and liver diseases: association or causation?Rinaldo Pellicano, Armelle Ménard, Mario Rizzetto, et al.
Transplantation|April 11, 2022
Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected RecipientsSilvia Martini, Francesco Tandoi, Renato Romagnoli, et al.
Critical Reviews in Microbiology|November 26, 2003
Helicobacter pylori and coronary heart disease: which directions for future studies?Rinaldo Pellicano, Sharmila Fagoonee, Mario Rizzetto, et al.
Annals of the New York Academy of Sciences|June 30, 2007
Studies of therapy with thymosin alpha1 in combination with pegylated interferon alpha2a and ribavirin in nonresponder patients with chronic hepatitis CRoberto Camerini, Alessia Ciancio, Alfonso DE Rosa, et al.
Antiviral Therapy|May 12, 2009
Management of hepatitis C virus genotype 2 or 3 infection: treatment optimization on the basis of virological responseStefan Zeuzem, Mario Rizzetto, Peter Ferenci, et al.
Current Clinical Pharmacology|May 9, 2012
An aggressive medical approach for inflammatory bowel disease: clinical challenges and therapeutic profiles in a retrospective hospital-based seriesGiovanni C Actis, Floriano Rosina, Rinaldo Pellicano, et al.
Pageof 20

Showing results (21-30 of 198) with videos related to

Sort By:
Pageof 20
Journal of Medical Virology|July 13, 2002
Progress in the prevention and control of viral hepatitis type B: closing remarksMario Rizzetto, Alessandro R Zanetti
Journal of Hepatology|January 23, 2021
The changing context of hepatitis DMario Rizzetto, Saeed Hamid, Franco Negro
Biomedicines|March 25, 2022
Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?Giorgio Maria Saracco, Alfredo Marzano, Mario Rizzetto
Viruses|August 26, 2022
A Review of HDV InfectionGian Paolo Caviglia, Alessia Ciancio, Mario Rizzetto
The Lancet. Infectious Diseases|March 21, 2008
Helicobacter species and liver diseases: association or causation?Rinaldo Pellicano, Armelle Ménard, Mario Rizzetto, et al.
Transplantation|April 11, 2022
Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected RecipientsSilvia Martini, Francesco Tandoi, Renato Romagnoli, et al.
Critical Reviews in Microbiology|November 26, 2003
Helicobacter pylori and coronary heart disease: which directions for future studies?Rinaldo Pellicano, Sharmila Fagoonee, Mario Rizzetto, et al.
Annals of the New York Academy of Sciences|June 30, 2007
Studies of therapy with thymosin alpha1 in combination with pegylated interferon alpha2a and ribavirin in nonresponder patients with chronic hepatitis CRoberto Camerini, Alessia Ciancio, Alfonso DE Rosa, et al.
Antiviral Therapy|May 12, 2009
Management of hepatitis C virus genotype 2 or 3 infection: treatment optimization on the basis of virological responseStefan Zeuzem, Mario Rizzetto, Peter Ferenci, et al.
Current Clinical Pharmacology|May 9, 2012
An aggressive medical approach for inflammatory bowel disease: clinical challenges and therapeutic profiles in a retrospective hospital-based seriesGiovanni C Actis, Floriano Rosina, Rinaldo Pellicano, et al.
Pageof 20